After a nationwide search, the Australian Nano Business Forum (ANBF) has announced the appointment of its Inaugural CEO, Ms Tina Rankovic. Ms Rankovic takes up her position at the peak body immediately.
Originally, from South Australia, Tina Rankovic is a senior executive with a strong business and technical background acquired in a range of business-to-business and service organisations. Her undergraduate qualifications are in applied science from Flinders University. She holds a Graduate Diploma of Management from the Royal Melbourne Institute of Technology and a Master of Business degree, majoring in innovation and marketing management, from the Australian Graduate School of Entrepreneurship at Swinburne University of Technology.
Ms Rankovic’s early career was in pharmaceutical and medical devices, including the Zimmer division of Bristol-Myers Squibb Australia, where her final position was that of Marketing and Business Development Director – Australasia. She then took up a role as National Business Development Manager – Orthopaedics for Mayne Group Ltd. She was recruited to become the inaugural Head of Commercialisation at the Baker Heart Research Institute in Melbourne from 2002 to early 2005, and was most recently the Director, Commercialisation - Life and Physical Sciences for Monash Commercial, the commercialisation vehicle for Monash University. During her business career, Ms Rankovic has also lived and worked in Sydney and Auckland.
ANBF Chairman Mr Brian Power; “We are delighted to appoint Tina to the ANBF. She brings an impressive track record in business development, and has already shown real insights into the issues facing the industry.” He added; “a national office is currently being established, and a program to introduce Ms Rankovic to all of the State and national stakeholders is being finalised”.
Ms Rankovic joins the ANBF at a challenging but exciting time, and recognizes the opportunity: “I am thrilled to be joining the Australian Nano Business Forum at such a critical time in the development of Australia's nanotechnology efforts. Nanotechnology offers the potential to rejuvenate and grow existing businesses, as well as develop new businesses across a wide range of consumer and industrial applications - the diversity spans medical solutions to previously untreatable diseases, materials for all types of products as well as possible applications in two key resources with finite supply: water and energy. I have been most impressed by the interest shown by a large number of companies already in having a coordination mechanism and a voice on nanotechnology policy topics”
The ANBF expects to be fully operational by mid-January. Over the next two months the organization will develop its package of membership services, and finalise its financial proposition for both existing and potential Members.